Comparing the Safety and Effectiveness of Tunnel PICC Guided by EDUG and Conventional PICC

NCT05621473 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 420

Last updated 2022-11-18

No results posted yet for this study

Summary

This study was designed as a prospective, multicenter, randomized controlled study, with the incidence of postoperative complications as the main observation end point. It was a superiority design.The purpose of this study was to compare the incidence of complications associated with EDUG-guided subcutaneous tunneling and conventional puncture after peripheral vein placement of PICCs

Conditions

  • the Incidence of PICC-related Complications

Interventions

DEVICE

PICC

Tunnel PICC puncture technology is a perfect combination of ultrasound-guided puncture, ECG lead technology, PICC and subcutaneous tunnel. The valve conduction PICC is equipped with an integrated ECG lead Doppler ultrasound machine. Before the catheter is placed, in the yellow area, in the ultrasound mode, evaluate the blood vessel condition, measure the blood flow velocity, and correctly select the puncture site. When the catheter is pushed close to the superior vena cava, the electrocardiograph mode is switched to complete the precise positioning of the catheter according to the principle of ECG positioning technology. A subcutaneous tunnel was prepared in the green area, and the PICC at the puncture site in the yellow area was introduced to the green area and carefully bandaged. Whole-process integrated operation, simple and efficient operation.

Sponsors & Collaborators

  • Wuhan University

    collaborator OTHER
  • Enshi Clinical College of Wuhan University

    collaborator UNKNOWN
  • Jingzhou Central Hospital

    collaborator OTHER
  • The Central Hospital of Huanggang

    collaborator OTHER
  • Hubei Cancer Hospital

    collaborator OTHER
  • Yichang Central People's Hospital

    collaborator OTHER
  • Sinopharm Gezhouba Group Central Hospital

    collaborator UNKNOWN
  • Central Hospital of Xiaogan

    collaborator OTHER
  • Xiaogan First People's Hospital

    collaborator UNKNOWN
  • Wuhan Central Hospital

    collaborator OTHER
  • Xiangyang Central Hospital

    collaborator OTHER
  • Xiangyang No.1 People's Hospital

    collaborator OTHER
  • Shandong Branden Med.Device Co.,Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-12-01
Primary Completion
2023-07-30
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621473 on ClinicalTrials.gov